Navigation Links
Panelists Announced for Decision Resources Group One-day Biologics and Biosimilars Seminar in San Diego
Date:4/18/2013

BURLINGTON, Mass., April 18, 2013 /PRNewswire/ -- Decision Resources Group is pleased to announce a distinguished lineup of speakers who will be joining its well-regarded Competitive Landscape Seminar Series focusing on Biologics and Biosimilars on May 2, 2013 at the Hotel Solamar in San Diego, CA. The panel discussion will focus on the key issues affecting the success of the biologics and biosimilars market. Panelists will share their thoughts on market access for biosimilars, the role of indication extrapolation and automatic substitution, as well as their perspective on appropriate pricing models for brands and biosimilars as this dynamic market segment continues to evolve.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO )

Moderated by Andrew Merron , Ph.D., Senior Director, Biosimilars Research, BioTrends Research Group, panelists include:

  • John L. Fox , M.D., M.H.A., Associate Vice President of Medical Affairs, Priority Health, Michigan
  • Kjel A. Johnson , Senior Vice President, Strategy and Business Development at Magellan Pharmacy Services
  • Atheer A. Kaddis , Pharm.D., Senior Vice President, Sales and Business Development at Diplomat Specialty Pharmacy

Panelists will focus on the key issues affecting the biologics landscape and the emerging biosimilars sector based on the European experience of biosimilars to date and expectations for the U.S. Topics to be discussed will include the anticipated future trends in the biologics market and the challenges and drivers of biosimilar adoption in the U.S.

This Decision Resources Group Competitive Landscape Seminar is a one-day strategic informational event covering key issues in the biologics and biosimilars market and will include presentations from six prominent DRG analysts. The seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence.  Attendees are invited to engage with analysts and peers with a post-event reception.

For more information and to register, please visit:

http://www.competitivelandscapeseries.com/biologics-and-biosimilars

Media Contact:
Media interested in attending the seminar should contact Roy Strunin at rstrunin@dresources.com or 781-993-2515 for additional information.

About the Competitive Landscape Seminar Series

The Competitive Landscape Seminar Series: Biologics and Biosimilars will be held on May 2, 2013. This high-value, one-day seminar has been developed specifically for biopharmaceutical market research executives as well as biologics and biosimilars product teams. Expert analysts from Decision Resources Group companies—Decision Resources and BioTrends Research Group—will share their latest research findings on key biologics and biosimilars trends.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.


 


'/>"/>
SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gen-Probe Withdraws from Previously Announced Investor Presentations
2. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
3. LTCLINK-Tank Competition Announced To Introduce Your Emerging Product to the Aging Care Continuum
4. Delcath Announced Changes To Board Of Directors
5. Speakers Announced for the 2012 International Iridoid Research Symposium
6. Bausch + Lomb Announces Extension of Early Tender Date for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
7. Online Pharmacy Domain Policy Changes Announced by ICANN Registrar Internet.bs Corp.
8. Bausch + Lomb Announces Final Results for Its Previously Announced Tender Offer for Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3, U07190AA6 and 071707AP8)
9. Results from the Largest Known Cholesterol Survey Conducted in the U.S. Announced at the American Heart Associations Annual Scientific Sessions
10. Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
11. MEK162 Registration Path Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Investment Group (TGIG), has initiated cultivation and processing operations at its production facility, ... Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of proactive ...
Breaking Medicine News(10 mins):